These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37801405)

  • 1. Exploring the Binding Pathway of Novel Nonpeptidomimetic Plasmepsin V Inhibitors.
    Bobrovs R; Drunka L; Kanepe I; Jirgensons A; Caflisch A; Salvalaglio M; Jaudzems K
    J Chem Inf Model; 2023 Nov; 63(21):6890-6899. PubMed ID: 37801405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring Aspartic Protease Inhibitor Binding to Design Selective Antimalarials.
    Bobrovs R; Basens EE; Drunka L; Kanepe I; Matisone S; Velins KK; Andrianov V; Leitis G; Zelencova-Gopejenko D; Rasina D; Jirgensons A; Jaudzems K
    J Chem Inf Model; 2022 Jul; 62(13):3263-3273. PubMed ID: 35712895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.
    Hidaka K; Kimura T; Ruben AJ; Uemura T; Kamiya M; Kiso A; Okamoto T; Tsuchiya Y; Hayashi Y; Freire E; Kiso Y
    Bioorg Med Chem; 2008 Dec; 16(23):10049-60. PubMed ID: 18952439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Plasmodium falciparum plasmepsin V by ligand-based virtual screening.
    Meissner KA; Kronenberger T; Maltarollo VG; Trossini GHG; Wrenger C
    Chem Biol Drug Des; 2019 Mar; 93(3):300-312. PubMed ID: 30320974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the flap pocket of the antimalarial target plasmepsin II: the "55 % rule" applied to enzymes.
    Zürcher M; Gottschalk T; Meyer S; Bur D; Diederich F
    ChemMedChem; 2008 Feb; 3(2):237-40. PubMed ID: 17918177
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target.
    Nezami A; Luque I; Kimura T; Kiso Y; Freire E
    Biochemistry; 2002 Feb; 41(7):2273-80. PubMed ID: 11841219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution.
    Miura T; Hidaka K; Uemura T; Kashimoto K; Hori Y; Kawasaki Y; Ruben AJ; Freire E; Kimura T; Kiso Y
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4836-9. PubMed ID: 20634066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.
    Gambini L; Rizzi L; Pedretti A; Taglialatela-Scafati O; Carucci M; Pancotti A; Galli C; Read M; Giurisato E; Romeo S; Russo I
    PLoS One; 2015; 10(11):e0142509. PubMed ID: 26566224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting Structural Dynamics To Design Open-Flap Inhibitors of Malarial Aspartic Proteases.
    Bobrovs R; Jaudzems K; Jirgensons A
    J Med Chem; 2019 Oct; 62(20):8931-8950. PubMed ID: 31062983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C2-symmetric inhibitors of Plasmodium falciparum plasmepsin II: synthesis and theoretical predictions.
    Ersmark K; Feierberg I; Bjelic S; Hultén J; Samuelsson B; Aqvist J; Hallberg A
    Bioorg Med Chem; 2003 Aug; 11(17):3723-33. PubMed ID: 12901917
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Sharma PP; Kumar S; Kaushik K; Singh A; Singh IK; Grishina M; Pandey KC; Singh P; Potemkin V; Poonam ; Singh G; Rathi B
    J Biomol Struct Dyn; 2022 Nov; 40(18):8352-8364. PubMed ID: 33870856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II.
    Hidaka K; Kimura T; Tsuchiya Y; Kamiya M; Ruben AJ; Freire E; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3048-52. PubMed ID: 17400453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor binding to the plasmepsin IV aspartic protease from Plasmodium falciparum.
    Gutiérrez-de-Terán H; Nervall M; Ersmark K; Liu P; Janka LK; Dunn B; Hallberg A; Aqvist J
    Biochemistry; 2006 Sep; 45(35):10529-41. PubMed ID: 16939205
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Ji X; Wang Z; Chen Q; Li J; Wang H; Wang Z; Yang L
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azole-based non-peptidomimetic plasmepsin inhibitors.
    Kinena L; Leitis G; Kanepe-Lapsa I; Bobrovs R; Jaudzems K; Ozola V; Suna E; Jirgensons A
    Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800151. PubMed ID: 30063266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
    Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
    J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of hydrazides and hydrazine derivatives as novel aspartic protease inhibitors.
    Ahmed W; Rani M; Khan IA; Iqbal A; Khan KM; Haleem MA; Azim MK
    J Enzyme Inhib Med Chem; 2010 Oct; 25(5):673-8. PubMed ID: 20063996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of acridinyl hydrazides as potent aspartic protease inhibitors.
    Azim MK; Ahmed W; Khan IA; Rao NA; Khan KM
    Bioorg Med Chem Lett; 2008 May; 18(9):3011-5. PubMed ID: 18417344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum.
    Mohapatra SC; Tiwari HK; Singla M; Rathi B; Sharma A; Mahiya K; Kumar M; Sinha S; Chauhan SS
    J Biol Inorg Chem; 2010 Mar; 15(3):373-85. PubMed ID: 19946719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
    Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
    Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.